Genocea Announces Upcoming Data Presentations at Virtual SITC 2020
Will showcase clinical and immune response s from the ongoing GEN-009 Phase 1/2a trial Will provide a detailed introduction to GEN-011, an adoptive T cell therapy designed to improve upon the limitations of TIL and more...
Affimed Announces Presentation of Preclinical Data on AFM13-targeted NK cells at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Heidelberg, Germany, October 14, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that preclinical data from its collaboration with The more...
Curis Announces Abstract for CI-8993 Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
Curis Announces Abstract for CI-8993 Accepted for Presentation at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting PR Newswire LEXINGTON, Mass., Oct. 14, 2020 LEXINGTON, Mass. , Oct. 14, 2020 /PRNewswire/ — more...
The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020
The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020 PR Newswire KELOWNA, BC, Oct. 14, 2020 KELOWNA, BC , Oct. 14, 2020 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: more...
T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020
LEXINGTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2020 after more...
Quantum to Release Fiscal Second Quarter 2021 Financial Results and Host Investor Conference Call on Wednesday, October 28th
Quantum to Release Fiscal Second Quarter 2021 Financial Results and Host Investor Conference Call on Wednesday, October 28th PR Newswire SAN JOSE, Calif., Oct. 14, 2020 SAN JOSE, Calif. , Oct. 14, 2020 /PRNewswire/ — more...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers
WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX ) regarding possible breaches of fiduciary duties and other violations of law more...
Keytronic Corporation Announces First Quarter Reporting Date
SPOKANE VALLEY, Wash., Oct. 14, 2020 (GLOBE NEWSWIRE) — Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the first quarter of fiscal 2021 after market close on October more...
Celldex Initiates Early-Stage Antibody Study for Skin Disorder
Celldex Therapeutics, Inc. CLDX announced that it has initiated a phase Ib study to evaluate its monoclonal antibody candidate CDX-0159 in patients with chronic spontaneous urticaria (CSU), one of the most frequent skin diseases. Shares more...
Biotech Stock Roundup: REGN, GILD’s Coronavirus News & Other Pipeline Updates
The biotech sector was in focus in the past week with quite a few regulatory and other pipeline updates. While the development of antibodies and vaccines for coronavirus remains in focus in this sector as more...